Michael H. Davidson
Chief Executive Officer, Director, NewAmsterdam Pharma Co N.V.
Bought, 12 months
$0.2M
Sold, 12 months
$25.3M
Companies
1
Latest trade
Sep 14, 2026
Companies
NewAmsterdam Pharma Co N.V.Chief Executive Officer, Director +$0.2M −$25.3MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.
